Literature DB >> 11027676

Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE.

A P West1, M J Bennett, V M Sellers, N C Andrews, C A Enns, P J Bjorkman.   

Abstract

The transferrin receptor (TfR) interacts with two proteins important for iron metabolism, transferrin (Tf) and HFE, the protein mutated in hereditary hemochromatosis. A second receptor for Tf, TfR2, was recently identified and found to be functional for iron uptake in transfected cells (Kawabata, H., Germain, R. S., Vuong, P. T., Nakamaki, T., Said, J. W., and Koeffler, H. P. (2000) J. Biol. Chem. 275, 16618-16625). TfR2 has a pattern of expression and regulation that is distinct from TfR, and mutations in TfR2 have been recognized as the cause of a non-HFE linked form of hemochromatosis (Camaschella, C., Roetto, A., Cali, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., and Gasparini, P. (2000) Nat. Genet. 25, 14-15). To investigate the relationship between TfR, TfR2, Tf, and HFE, we performed a series of binding experiments using soluble forms of these proteins. We find no detectable binding between TfR2 and HFE by co-immunoprecipitation or using a surface plasmon resonance-based assay. The affinity of TfR2 for iron-loaded Tf was determined to be 27 nm, 25-fold lower than the affinity of TfR for Tf. These results imply that HFE regulates Tf-mediated iron uptake only from the classical TfR and that TfR2 does not compete for HFE binding in cells expressing both forms of TfR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027676     DOI: 10.1074/jbc.C000664200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

2.  Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.

Authors:  Junwei Gao; Juxing Chen; Ivana De Domenico; David M Koeller; Cary O Harding; Robert E Fleming; Dwight D Koeberl; Caroline A Enns
Journal:  Blood       Date:  2010-02-22       Impact factor: 22.113

Review 3.  Molecular insights into the pathogenesis of hereditary haemochromatosis.

Authors:  A Pietrangelo
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

Review 4.  Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2018-05-31       Impact factor: 11.848

5.  VIPER is a genetically encoded peptide tag for fluorescence and electron microscopy.

Authors:  Julia K Doh; Jonathan D White; Hannah K Zane; Young Hwan Chang; Claudia S López; Caroline A Enns; Kimberly E Beatty
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-05       Impact factor: 11.205

Review 6.  Transferrin receptor in tissue and serum: updated clinical significance of soluble receptor.

Authors:  Yutaka Kohgo; Yoshihiro Torimoto; Junji Kato
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

7.  Characterization of Tfrc-mutant mice with microcytic phenotypes.

Authors:  Ashlee J Conway; Fiona C Brown; Gerhard Rank; Benjamin T Kile; Craig J Morton; Stephen M Jane; David J Curtis
Journal:  Blood Adv       Date:  2018-08-14

8.  Function of the hemochromatosis protein HFE: Lessons from animal models.

Authors:  Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

9.  Transferrin-a modulates hepcidin expression in zebrafish embryos.

Authors:  Paula G Fraenkel; Yann Gibert; Jason L Holzheimer; Victoria J Lattanzi; Sarah F Burnett; Kimberly A Dooley; Rebecca A Wingert; Leonard I Zon
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

Review 10.  The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.

Authors:  Kimberly Zumbrennen-Bullough; Jodie L Babitt
Journal:  Nephrol Dial Transplant       Date:  2013-11-13       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.